Rapamycin Impairs In Vivo Proliferation of Islet Beta-Cells

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Transplantation

• Publication date

  2007-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/01.tp.0000296035.48728.28PMID 18165767
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sirolimus toxicity and vascular endothelial growth factor release from islet and renal cell lines.

  2007cited by this paper
• The l-isoform but not d-isoforms of a JNK inhibitory peptide protects pancreatic beta-cells.

  2007cited by this paper
• In Vivo and In Vitro Effect of Sirolimus on Insulin Secretion

  2007cited by this paper
• Intrinsic Regulators of Pancreatic β-Cell Proliferation

  2006cited by this paper
• Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes

  2006cited by this paper
• Calcineurin/NFAT signalling regulates pancreatic β-cell growth and function

  2006cited by this paper
• Induction of Tolerance in Type 1 Diabetes via Both CD4+CD25+ T Regulatory Cells and T Regulatory Type 1 Cells

  2006cited by this paper
• Increased Pancreatic β-Cell Proliferation Mediated by CREB Binding Protein Gene Activation

  2006cited by this paper
• TOR signaling in growth and metabolism.

  2006cited by this paper
• In Human Endothelial Cells Amino Acids Inhibit Insulin-induced Akt and ERK1/2 Phosphorylation by an mTOR-dependent Mechanism

  2006influential reference
• International trial of the Edmonton protocol for islet transplantation.

  2006cited by this paper
• Antiangiogenic and Immunomodulatory Effects of Rapamycin on Islet Endothelium: Relevance for Islet Transplantation

  2006cited by this paper
• Sirolimus Is Associated With Reduced Islet Engraftment and Impaired β-Cell Function

  2006cited by this paper
• Increased islet beta cell replication adjacent to intrapancreatic gastrinomas in humans

  2006cited by this paper
• The impact of the mTOR inhibitor sirolimus on the proliferation and function of pancreatic islets and ductal cells

  2006influential reference
• mTOR Inhibition Induces Endothelial Progenitor Cell Death

  2006cited by this paper
• Intrinsic regulators of pancreatic beta-cell proliferation.

  2006cited by this paper
• Complexity of the TOR signaling network.

  2006cited by this paper
• Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function.

  2006cited by this paper
• Glucose-stimulated DNA Synthesis through Mammalian Target of Rapamycin (mTOR) Is Regulated by KATP Channels

  2006cited by this paper
• A Novel Method for the Assessment of Cellular Composition and Beta‐Cell Viability in Human Islet Preparations

  2005cited by this paper
• Islet Transplantation in Type 1 Diabetes Mellitus Using Cultured Islets and Steroid‐Free Immunosuppression: Miami Experience

  2005cited by this paper
• Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration?

  2005cited by this paper
• Signaling by Target of Rapamycin Proteins in Cell Growth Control

  2005cited by this paper
• Five-year follow-up after clinical islet transplantation.

  2005cited by this paper
• Hepatocyte growth factor gene therapy for pancreatic islets in diabetes: reducing the minimal islet transplant mass required in a glucocorticoid-free rat model of allogeneic portal vein islet transplantation.

  2004cited by this paper
• Distinctive roles for prolactin and growth hormone in the activation of signal transducer and activator of transcription 5 in pancreatic islets of langerhans.

  2004cited by this paper
• Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation.

  2004cited by this paper
• Participation of prolactin receptors and phosphatidylinositol 3-kinase and MAP kinase pathways in the increase in pancreatic islet mass and sensitivity to glucose during pregnancy.

  2004cited by this paper
• Signaling elements involved in the metabolic regulation of mTOR by nutrients, incretins, and growth factors in islets.

  2004cited by this paper
• Sirolimus and islet transplants.

  2003cited by this paper
• Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets.

  2003cited by this paper
• Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody1

  2003cited by this paper
• Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: local immunosuppression or islet toxicity?

  2003cited by this paper
• Targeted deletion of the PRL receptor: effects on islet development, insulin production, and glucose tolerance.

  2002cited by this paper
• An Immunohistochemical Approach to Monitor the Prolactin-induced Activation of the JAK2/STAT5 Pathway in Pancreatic Islets of Langerhans

  2002cited by this paper
• FRAP/mTOR is required for proliferation and patterning during embryonic development in the mouse

  2001cited by this paper
• Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5).

  2001cited by this paper
• Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.

  2000cited by this paper
• Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen

  2000influential reference
• Hypoinsulinaemia, glucose intolerance and diminished β-cell size in S6K1-deficient mice

  2000cited by this paper
• Adaptation of pancreatic islet B-cells during the last third of pregnancy: regulation of B-cell function and proliferation by lactogenic hormones in rats.

  1999cited by this paper
• Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance

  1999cited by this paper
• Beta cell proliferation and growth factors

  1999cited by this paper
• Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154.

  1999cited by this paper
• Adaptation of Islets of Langerhans to Pregnancy: β-Cell Growth, Enhanced Insulin Secretion and the Role of Lactogenic Hormones

  1997cited by this paper
• In vitro studies of the stimulation of insulin secretion and B-cell proliferation by rat placental lactogen-II during pregnancy in rats.

  1997cited by this paper
• Role of increased insulin demand in the adaptation of the endocrine pancreas to pregnancy.

  1997cited by this paper
• Effects of glibenclamide on pancreatic β-cell proliferation in vivo

  1994influential reference
• Effects of glibenclamide on pancreatic beta-cell proliferation in vivo.

  1994cited by this paper
• Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle

  1993cited by this paper
• A Second Pathway for Regeneration of Adult Exocrine and Endocrine Pancreas: A Possible Recapitulation of Embryonic Development

  1993cited by this paper
• Effect of homologous placental lactogens, prolactins, and growth hormones on islet B-cell division and insulin secretion in rat, mouse, and human islets: implication for placental lactogen regulation of islet function during pregnancy.

  1993cited by this paper
• Adaptation of islets of Langerhans to pregnancy: increased islet cell proliferation and insulin secretion correlates with the onset of placental lactogen secretion.

  1992cited by this paper
• In vivo effect of FK506 on human pancreatic islets.

  1991cited by this paper

• Chronic kidney disease combined with metabolic syndrome is a non-negligible risk factor

  2024cites this paper
• Small-molecule inhibitors of the CD40–CD40L costimulatory interaction are effective in pancreatic islet transplantation and prevention of type 1 diabetes models

  2024cites this paper
• Obesity-associated Inflammation and Alloimmunity

  2024cites this paper
• Exploring the molecular mechanisms of macrophages in islet transplantation using single-cell analysis

  2024cites this paper
• Reversal of experimental autoimmune diabetes with a sCD39/anti-CD3 treatment.

  2023cites this paper
• Cardiovascular Protective Effects of NP-6A4, a Drug with the FDA Designation for Pediatric Cardiomyopathy, in Female Rats with Obesity and Pre-Diabetes

  2023cites this paper
• Stem cells differentiation into insulin-producing cells (IPCs): recent advances and current challenges

  2022cites this paper
• A nanofibrous encapsulation device for safe delivery of insulin-producing cells to treat type 1 diabetes

  2021cites this paper
• GRB10 regulates β cell mass by inhibiting β cell proliferation and stimulating β cell dedifferentiation.

  2021cites this paper
• Local Immunomodulatory Strategies to Prevent Allo‐Rejection in Transplantation of Insulin‐Producing Cells

  2021cites this paper
• Proper mTORC1 activity is required for glucose sensing and early adaptation in human pancreatic beta cell.

  2020cites this paper
• Glycogen phosphorylase inhibitor, 2,3‐bis[(2E)‐3‐(4‐hydroxyphenyl)prop‐2‐enamido] butanedioic acid (BF142), improves baseline insulin secretion of MIN6 insulinoma cells

  2020cites this paper
• Protection of Pancreatic Islets Using Theranostic Silencing Nanoparticles in a Baboon Model of Islet Transplantation

  2020cites this paper
• METABOLIC ADAPTATIONS TO PREGNANCY IN HEALTHY AND GESTATIONAL DIABETIC PREGNANCIES: THE PANCREAS - PLACENTA AXIS.

  2020cites this paper
• Gestational Glucose Metabolism: Focus on the Role and Mechanisms of Insulin Resistance

  2020cites this paper
• Metabolic Consequences of Solid Organ Transplantation.

  2020cites this paper
• In vivo imaging of type 1 diabetes immunopathology using eye-transplanted islets in NOD mice

  2019cites this paper
• Mammalian Target of Rapamycin at the Crossroad Between Alzheimer's Disease and Diabetes.

  2019cites this paper
• Engineering the vasculature for islet transplantation.

  2019cites this paper
• Post-transplant diabetes mellitus in patients with solid organ transplants

  2019cites this paper
• (Re)generating Human Beta Cells: Status, Pitfalls, and Perspectives.

  2018cites this paper
• Novel metabolic effects of glycogen phosphorylase inhibitors

  2017cites this paper
• Overexpression of Kinase-Dead mTOR Impairs Glucose Homeostasis by Regulating Insulin Secretion and Not β-Cell Mass

  2017cites this paper
• Raptor regulates functional maturation of murine beta cells

  2017cites this paper
• β‐Cell adaptation in pregnancy

  2016cites this paper
• mTOR Inhibition: Reduced Insulin Secretion and Sensitivity in a Rat Model of Metabolic Syndrome

  2016cites this paper
• Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes.

  2016cites this paper
• PKCζ Is Essential for Pancreatic β-Cell Replication During Insulin Resistance by Regulating mTOR and Cyclin-D2

  2016cites this paper
• mTORC1 pathway mediates beta cell compensatory proliferation in 60 % partial-pancreatectomy mice

  2016cites this paper
• Gastrointestinal Tract and Endocrine System

  2016cites this paper
• Advances in β cell replacement and regeneration strategies for treating diabetes.

  2016cites this paper
• Monitoring of Allogeneic Islet Grafts in Nonhuman Primates Using MRI

  2015cites this paper
• Biphasic decline of β‐cell function with age in euglycemic nonobese diabetic mice parallels diabetes onset

  2015cites this paper
• The two faces of miR-29

  2015cites this paper
• Clinical Immunosuppressants Inhibit Inflammatory, Proliferative, and Reprogramming Potential, But not Angiogenesis of Human Pancreatic Duct Cells

  2015cites this paper
• Intracellular sirolimus concentration is reduced by tacrolimus in human pancreatic islets in vitro

  2015cites this paper
• Pancreatic β-Cell Failure Mediated by mTORC1 Hyperactivity and Autophagic Impairment

  2014cites this paper
• Engraftment Versus Immunosuppression: Cost-Benefit Analysis of Immunosuppression After Intrahepatic Murine Islet Transplantation

  2014cites this paper
• Role of the mammalian target of rapamycin (mTOR) complexes in pancreatic β-cell mass regulation.

  2014cites this paper
• Mediators and markers of mammalian lifespan extension: Proteomic, proliferative and hormonal adaptations in mouse models of extended lifespan

  2014cites this paper
• Overcoming barriers in clinical islet transplantation: current limitations and future prospects.

  2014cites this paper
• Rapamycin Ameliorates Nephropathy despite Elevating Hyperglycemia in a Polygenic Mouse Model of Type 2 Diabetes, NONcNZO10/LtJ

  2014cites this paper
• Phosphorylation of ribosomal protein S6 attenuates DNA damage and tumor suppression during development of pancreatic cancer.

  2013cites this paper
• Immunosupppression and Endocrine Dysfunction

  2013cites this paper
• MicroRNA-7 Control of β-Cell Replication

  2013cites this paper
• Molecular and Cellular Pathobiology Phosphorylation of Ribosomal Protein S 6 Attenuates DNA Damage and Tumor Suppression during Development of Pancreatic Cancer

  2013cites this paper
• Transdisciplinary approach to restore pancreatic islet function

  2013cites this paper
• Transdisciplinary approach to restore pancreatic islet function

  2013cites this paper
• Evidence for Rapamycin Toxicity in Pancreatic β-Cells and a Review of the Underlying Molecular Mechanisms

  2013cites this paper
• Effect of the Purinergic Inhibitor Oxidized ATP in a Model of Islet Allograft Rejection

  2013cites this paper
• Metformin Improves Immunosuppressant Induced Hyperglycemia and Exocrine Apoptosis in Rats

  2013cites this paper
• Maturation and function of human embryonic stem cell-derived pancreatic progenitors in macroencapsulation devices following transplant into mice

  2013cites this paper
• Mesenchymal stromal cells as a means of controlling pathological T-cell responses in allogeneic islet transplantation

  2013cites this paper
• Chapter 70 – Islet Cell Therapy and Pancreatic Stem Cells

  2013cites this paper
• A Theranostic Small Interfering RNA Nanoprobe Protects Pancreatic Islet Grafts From Adoptively Transferred Immune Rejection

  2012cites this paper
• Human β-Cell Proliferation and Intracellular Signaling

  2012cites this paper
• Rapamycin Causes Upregulation of Autophagy and Impairs Islets Function Both In Vitro and In Vivo

  2012cites this paper
• Adaptive changes of human islets to an obesogenic environment in the mouse

  2012cites this paper
• Molecular Regulators of Metabolism and Cardiometabolic Disease

  2012cites this paper
• Regeneration of pancreatic beta-cell mass for the treatment of diabetes

  2012cites this paper
• Immune modulation with amniotic epithelial cells in pancreatic islet transplantation

  2012cites this paper
• mTORC1 signaling and regulation of pancreatic β-cell mass

  2012cites this paper
• Prevention of Autoimmune Diabetes and Induction of β-Cell Proliferation in NOD Mice by Hyperbaric Oxygen Therapy

  2012cites this paper
• Activation of Protein Kinase C-ζ in Pancreatic β-Cells In Vivo Improves Glucose Tolerance and Induces β-Cell Expansion via mTOR Activation

  2011cites this paper
• Alternative Transplantation Sites for Pancreatic Islet Grafts

  2011cites this paper
• Mesenchymal Stromal Cells as a Therapeutic Strategy to Support Islet Transplantation in Type 1 Diabetes Mellitus.

  2011cites this paper
• The Use of Biomaterials in Islet Transplantation

  2011cites this paper
• Type 1 diabetes: etiology, immunology, and therapeutic strategies.

  2011cites this paper
• Mechanisms in the adaptation of maternal β-cells during pregnancy.

  2011cites this paper
• Evolution of β-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell Transplantation

  2011cites this paper
• Islets transplanted in immunoisolation devices: a review of the progress and the challenges that remain.

  2011cites this paper
• Improved Quantification of Islet Transplants by Magnetic Resonance Imaging With Resovist

  2011cites this paper
• Rapamycin Impairs Proliferation of Transplanted Islet &bgr; Cells

  2011influential citation
• Targeted deletion of one or two copies of the G protein β subunit Gβ5 gene has distinct effects on body weight and behavior in mice

  2011cites this paper
• Mechanisms of Rapamycin Toxicity in Pancreatic Beta Cells

  2011cites this paper
• Kidney and Pancreas Transplantation

  2011cites this paper
• Islet Cell Therapy and Pancreatic Stem Cells

  2011cites this paper
• Mechanisms in the adaptation of maternal b-cells during pregnancy Review

  2011cites this paper
• Betazellregeneration transplantierter Inseln im Mausmodell

  2010cites this paper
• Bone marrow-derived stem cell transplantation for the treatment of insulin-dependent diabetes.

  2010cites this paper
• Manual Posttransplantation diabetes Mellitus

  2010cites this paper
• DIABETIC STUDIES The Review of Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Insulin-Dependent Diabetes

  2010cites this paper
• Supplemental Islet Infusions Restore Insulin Independence After Graft Dysfunction in Islet Transplant Recipients

  2010cites this paper
• Mammalian target of rapamycin inhibition abrogates insulin-mediated mammary tumor progression in type 2 diabetes.

  2010cites this paper
• Prolactin Supplementation to Culture Medium Improves &bgr;-Cell Survival

  2010cites this paper
• Local Expression of Indoleamine 2,3 Dioxygenase in Syngeneic Fibroblasts Significantly Prolongs Survival of an Engineered Three-Dimensional Islet Allograft

  2010cites this paper
• Role of the TSC1-TSC2 complex in the integration of insulin and glucose signaling involved in pancreatic beta-cell proliferation.

  2010cites this paper
• Hyperglycemia induced by tacrolimus and sirolimus is reversible in normal sprague–dawley rats

  2010cites this paper
• Roles of Ets-1 and p70S6 kinase in chondrogenic and gliogenic specification of mouse mesencephalic neural crest cells.

  2010cites this paper
• TSC1/TSC2 Signaling in Pancreatic β-Cells

  2010cites this paper
• Feasibility of localized immunosuppression: 1. Exploratory studies with glucocorticoids in a biohybrid device designed for cell transplantation.

  2010cites this paper
• Rapamycin Suppresses the Expansion and Differentiation of Porcine Neonatal Pancreas Cell Clusters

  2010cites this paper
• Evaluation of strategies to predict and improve early graft survival in clinical islet transpalntation

  2010cites this paper
• EVALUATION OF STRATEGIES TO PREDICT AND IMPROVE EARLY GRAFT SURVIVAL IN CLINICAL ISLET TRANSPLANTATION

  2010cites this paper
• Use of a cocktail regimen consisting of soluble galectin-1, rapamycin and histone deacetylase inhibitor may effectively prevent type 1 diabetes.

  2009cites this paper
• Islet and Pancreas Transplantation

  2009cites this paper
• Current Advances and Travails in Islet Transplantation

  2009cites this paper
• Long‐Term Insulin‐Independence After Allogeneic Islet Transplantation for Type 1 Diabetes: Over the 10‐Year Mark

  2009cites this paper
• Marginal mass islet transplantation with autologous mesenchymal stem cells promotes long-term islet allograft survival and sustained normoglycemia.

  2009cites this paper
• Effects of systemic immunosuppression on islet engraftment and function into a subcutaneous biocompatible device.

  2009cites this paper